Sort
326,823 grants matching “clinical trial”
HDL Mimetic Peptide-Mediated Enhancement of Neurovascular Function to Mitigate Cerebral Amyloid Angiopathy and Alzheimer's Disease
$1,884,326Ling Li · University Of Minnesota · RF1 · FY2018 · AG
Developmental Funds
$1,884,317Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2018 · CA
Developmental Funds
$1,884,315Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2019 · CA
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$1,884,250James D Bearden · Spartanburg Regional Medical Center · U10 · FY2009 · CA
Therapies for patients with rare tumors and genetic tumor predisposition
$1,884,219Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Community Clinical Oncology Program Research Base
$1,884,051Brad H. Pollock · Children'S Hosp Of Philadelphia · U10 · FY2013 · CA
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
$1,884,019Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2011 · CA
Immune Modulation/Hematopoietic Cell Transplantation
$1,883,752Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2009 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$1,883,671Vanderbilt University · U01 · FY2005 · AI
GHESKIO HIV Clinical Trial Unit
$1,883,418Jean William Pape · Gheskio Center · UM1 · FY2019 · AI
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier
$1,883,383Kari C. Nadeau · Harvard School Of Public Health · U01 · FY2023 · AI
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,883,308E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$1,883,039Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
ADULT AIDS CLINICAL TRIAL UNIT
$1,882,971University Of Texas Medical Br Galveston · U01 · FY2000 · AI
Clinical Trials Reporting Porgram (CTRP) Program and Technical Support Services
$1,882,730National Cancer Institute · Y01 · FY2020 · CA
Gene Therapy Approaches for Primary Immunodeficiencies
$1,882,685Fabio Candotti · Human Genome Research · Z01 · FY2007 · HG
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders
$1,882,638Stanley Sacks · National Development And Research Institutes, Inc. · RC2 · FY2009 · DA
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial
$1,881,836David W. Carley · University Of Illinois At Chicago · UM1 · FY2014 · HL
SPORE in Myeloid Malignancies
$1,881,692Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA
HTS enabled examination of drug combinations
$1,881,570Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Prostate Cancer Studies
$1,881,540Ann Hsing · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
SPORE in Prostate Cancer
$1,881,489Samuel R Denmeade · Johns Hopkins University · P50 · FY2018 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,881,400Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2005 · AI
SPORE In Prostate Cancer
$1,881,400Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2014 · CA
Johns Hopkins Alzheimer's Disease Research Center
$1,881,193Marilyn S Albert · Johns Hopkins University · P50 · FY2015 · AG